For example, earlier prospective studies identified that the associations of Lp(a) with the risk of CVDs may be more marked among individuals with elevated LDL cholesterol [4, 5], and treating elevated LDL-C in those with elevated Lp(a) has been shown to attenuate the increased risk of coronary artery disease (CAD) [6]. Here, LPA is linked to coronary artery disorder.